X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (68414) 68414
Publication (6539) 6539
Book Review (526) 526
Magazine Article (172) 172
Book Chapter (63) 63
Conference Proceeding (50) 50
Newsletter (42) 42
Dissertation (36) 36
Book / eBook (32) 32
Trade Publication Article (12) 12
Paper (11) 11
Data Set (8) 8
Web Resource (6) 6
Government Document (2) 2
Journal / eJournal (2) 2
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47119) 47119
index medicus (43256) 43256
anti-bacterial agents - pharmacology (30942) 30942
anti-bacterial agents - therapeutic use (24732) 24732
female (21216) 21216
male (20964) 20964
microbiology (18225) 18225
microbial sensitivity tests (18099) 18099
antibiotics (16286) 16286
animals (13841) 13841
infectious diseases (13749) 13749
middle aged (12586) 12586
adult (12544) 12544
pharmacology & pharmacy (11528) 11528
anti-bacterial agents - administration & dosage (11017) 11017
aged (10077) 10077
bacteria (9399) 9399
infections (7539) 7539
treatment outcome (7228) 7228
health aspects (7145) 7145
drug resistance, bacterial (7136) 7136
analysis (6995) 6995
anti-bacterial agents - chemistry (6920) 6920
adolescent (6093) 6093
drug resistance (5917) 5917
research (5825) 5825
child (5678) 5678
drug resistance in microorganisms (5487) 5487
resistance (5416) 5416
infection (5400) 5400
retrospective studies (5321) 5321
risk factors (5052) 5052
antibacterial agents (4751) 4751
aged, 80 and over (4645) 4645
antimicrobial agents (4577) 4577
child, preschool (4476) 4476
prevalence (4423) 4423
staphylococcus aureus - drug effects (4343) 4343
escherichia coli - drug effects (4188) 4188
epidemiology (4101) 4101
antimicrobial resistance (4092) 4092
research article (4084) 4084
care and treatment (4060) 4060
escherichia-coli (4022) 4022
young adult (3973) 3973
medicine (3889) 3889
anti-bacterial agents - adverse effects (3825) 3825
bacteria - drug effects (3796) 3796
infant (3773) 3773
infectious disease (3742) 3742
surgery (3666) 3666
biotechnology & applied microbiology (3662) 3662
prospective studies (3585) 3585
anti-bacterial agents - pharmacokinetics (3543) 3543
internal medicine (3539) 3539
immunology (3506) 3506
time factors (3433) 3433
hospitals (3427) 3427
management (3364) 3364
mortality (3286) 3286
children (3284) 3284
medicine, general & internal (3230) 3230
staphylococcus aureus (3196) 3196
pneumonia (3182) 3182
drug resistance, multiple, bacterial (3164) 3164
therapy (3157) 3157
biochemistry & molecular biology (3065) 3065
diagnosis (2983) 2983
susceptibility (2979) 2979
antibiotic resistance (2938) 2938
antibacterial activity (2927) 2927
genes (2873) 2873
vancomycin (2824) 2824
drug therapy (2822) 2822
medicine & public health (2793) 2793
drug therapy, combination (2782) 2782
pathogens (2767) 2767
strains (2719) 2719
bacterial proteins - genetics (2688) 2688
studies (2636) 2636
usage (2627) 2627
pediatrics (2587) 2587
escherichia coli (2582) 2582
identification (2551) 2551
antibiotic-resistance (2541) 2541
mice (2528) 2528
staphylococcal infections - microbiology (2520) 2520
pseudomonas aeruginosa - drug effects (2511) 2511
chemistry, medicinal (2445) 2445
antimicrobial activity (2441) 2441
veterinary sciences (2418) 2418
bacterial infections - drug therapy (2404) 2404
article (2402) 2402
anti-bacterial agents (2398) 2398
in-vitro (2380) 2380
multidisciplinary sciences (2358) 2358
dose-response relationship, drug (2349) 2349
ciprofloxacin (2319) 2319
e coli (2273) 2273
pharmacokinetics (2269) 2269
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (14) 14
Online Resources - Online (6) 6
Chemistry (A D Allen) - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Mississauga - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Periodical Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (66861) 66861
Japanese (432) 432
German (403) 403
French (296) 296
Spanish (251) 251
Russian (241) 241
Chinese (150) 150
Dutch (127) 127
Turkish (67) 67
Polish (58) 58
Italian (50) 50
Korean (44) 44
Danish (32) 32
Swedish (32) 32
Portuguese (31) 31
Czech (28) 28
Hungarian (20) 20
Romanian (20) 20
Norwegian (19) 19
Ukrainian (13) 13
Hebrew (11) 11
Persian (10) 10
Serbian (10) 10
Croatian (8) 8
Bulgarian (7) 7
Lithuanian (7) 7
Arabic (5) 5
Finnish (2) 2
Slovak (2) 2
Slovenian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of antimicrobial agents, ISSN 0924-8579, 1991
Journal
Intensive care medicine, ISSN 0342-4642, 2017, Volume 43, Issue 3, pp. 304 - 377
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 2007, Volume 69, Issue 1, pp. 91 - 102
Objective: To provide evidence-based recommendations on the treatment of nervous system Lyme disease and post-Lyme syndrome. Three questions were addressed: 1)... 
ORAL DOXYCYCLINE | BORRELIA-BURGDORFERI | INTRAVENOUS CEFTRIAXONE | PENICILLIN-G | ANTIMICROBIAL AGENTS | FOLLOW-UP | IN-VITRO SUSCEPTIBILITY | CLINICAL NEUROLOGY | NEUROBORRELIOSIS | CHILDREN | MANIFESTATIONS | Headache - etiology | Humans | Fatigue - etiology | Male | Penicillins - administration & dosage | Lyme Neuroborreliosis - complications | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Cognition Disorders - etiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Child | Prednisone - administration & dosage | Drug Administration Schedule | Penicillins - therapeutic use | Administration, Oral | Doxycycline - therapeutic use | Infusions, Parenteral | Treatment Outcome | Lyme Neuroborreliosis - diagnosis | Cranial Nerve Diseases - drug therapy | Evidence-Based Medicine | Lyme Neuroborreliosis - drug therapy | Syndrome | Randomized Controlled Trials as Topic | Cranial Nerve Diseases - etiology | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Chronic Disease | Prednisone - therapeutic use | Borrelia burgdorferi - drug effects | Headache | MEDICIN OCH HÄLSOVETENSKAP | Oral | Cranial Nerve Diseases | Anti-Bacterial Agents | administration & dosage | Combination | pharmacology | MEDICAL AND HEALTH SCIENCES | Lyme Neuroborreliosis | Administration | Borrelia burgdorferi | drug therapy | complications | Parenteral | Infusions | drug effects | Fatigue | diagnosis | Prednisone | etiology | Randomized Controlled Trials | Cognition Disorders | Penicillins | Doxycycline | adverse effects | therapeutic use
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 9/2012, Volume 26, Issue 9, pp. 1185 - 1193
The onset and early course of schizophrenia is associated with subtle loss of grey matter which may be responsible for the evolution and persistence of... 
anti-inflammatory | Schizophrenia | minocycline | neuroprotection | glutamate | negative symptoms | NADPH OXIDASE | ACTIVATION | HALOPERIDOL | PSYCHIATRY | FOLLOW-UP | OPEN-LABEL | NEUROSCIENCES | CLINICAL NEUROLOGY | THERAPY | IN-VIVO | PHARMACOLOGY & PHARMACY | DYSFUNCTION | 1ST-EPISODE PSYCHOSIS | VOLUME CHANGES | Neuroprotective Agents - therapeutic use | Antipsychotic Agents - adverse effects | Cognition Disorders - chemically induced | Humans | Male | Patient Dropouts | Schizophrenic Psychology | Young Adult | Anti-Bacterial Agents - therapeutic use | Minocycline - adverse effects | Psychiatric Status Rating Scales | Cognition Disorders - prevention & control | Pakistan | Antipsychotic Agents - therapeutic use | Minocycline - therapeutic use | Schizophrenia - physiopathology | Brazil | Adult | Female | Anti-Bacterial Agents - adverse effects | Neuroprotective Agents - adverse effects | Severity of Illness Index | Double-Blind Method | Neurotoxicity Syndromes - prevention & control | Adolescent | Intention to Treat Analysis | Schizophrenia - drug therapy | Symptomatology | Minocycline | Clinical trials | Dosage and administration | Drug therapy | Testing | Emotional behavior | Neuroprotection | Neuroleptics | Mental disorders | Withdrawal | Inflammation | Substantia grisea | Emotions | Psychosis | Antibiotics | Tau protein | Evolution
Journal Article
Journal Article